GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the mycobacterium tuberculosis L,D- transpeptidase-2 (LDTMT2) bc-module with thionitrobenzoate (tnb) adduct at the active site cysteine-354

Analyse Crystal structure of the mycobacterium tuberculosis L,D- transpeptidase-2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5LB1
Type
protein
Length
511 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
L,D-transpeptidase 2
EC
2.3.2.-
UniProt
I6Y9J2
Ligands
MNB
Pockets
2 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AL,D-transpeptidase 2 (EC 2.3.2.-)protein25812% helix, 40% strandI6Y9J2
BL,D-transpeptidase 2 (EC 2.3.2.-)protein25312% helix, 41% strandI6Y9J2

Ligands and binding sites

  • MNB · 5-mercapto-2-nitro-benzoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19910.770.79103MNB
24370.630.7745MNB

Interfaces

1 interface between chains.

  • A–B · 645 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 5LB1 · Crystal structure of the Mycobacterium tuberculosis L,D-transpeptidase-2 (LdtMt2)… · the same entry in another collection · chain A against A, TM-score 1.00
  • I6Y9J2 · AlphaFold monomer V2.0 prediction for L,D-transpeptidase 2 (I6Y9J2) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.